CA

Les Laboratoires Aeterna, Inc.


USPTO Granted Patents = 8

% Expired Patents = 25.0


Trademarks = 1

Forward Citations = 88

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Eric Dupont (6 out of 8 patents)

silverMedal Christina Juneau (4 out of 4 patents)

bronzeMedal Paul Brazeau (4 out of 15 patents)

4.  Daniel H Maes (3 out of 37 patents)

5.  Kenneth D Marenus (3 out of 16 patents)

6.  Serge Auger (2 out of 4 patents)

7.  Richard Béliveau (2 out of 2 patents)

8.  Éric Dupont (2 out of 2 patents)

9.  Denis Lessard (2 out of 4 patents)

10.  Yves Lachance (2 out of 2 patents)

11.  Kenneth Marenus (0 patent)


8 patents:

Company Overview
Les Laboratoires Aeterna, Inc. is a leading pharmaceutical company specializing in the development and commercialization of innovative medical solutions. With a focus on research and development, Aeterna is committed to improving patient outcomes and quality of life. Our products span a variety of therapeutic areas including oncology, dermatology, and infectious diseases. Visit our website to learn more about our latest advancements and partnerships.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#196 in

#1,878 in Canada

CA
CA
Forward Citations = 88

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Les Laboratoires Aeterna, Inc.. Retrieved from https://idiyas.com/company/les-laboratoires-aeterna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…